These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
454 related articles for article (PubMed ID: 31605710)
1. MiR-216b-5p inhibits cell proliferation in human breast cancer by down-regulating HDAC8 expression. Menbari MN; Rahimi K; Ahmadi A; Elyasi A; Darvishi N; Hosseini V; Mohammadi-Yeganeh S; Abdi M Life Sci; 2019 Nov; 237():116945. PubMed ID: 31605710 [TBL] [Abstract][Full Text] [Related]
2. miR-483-3p suppresses the proliferation and progression of human triple negative breast cancer cells by targeting the HDAC8>oncogene. Menbari MN; Rahimi K; Ahmadi A; Mohammadi-Yeganeh S; Elyasi A; Darvishi N; Hosseini V; Abdi M J Cell Physiol; 2020 Mar; 235(3):2631-2642. PubMed ID: 31508813 [TBL] [Abstract][Full Text] [Related]
3. MicroRNA-216b is Down-Regulated in Human Gastric Adenocarcinoma and Inhibits Proliferation and Cell Cycle Progression by Targeting Oncogene HDAC8. Wang Y; Xu P; Yao J; Yang R; Shi Z; Zhu X; Feng X; Gao S Target Oncol; 2016 Apr; 11(2):197-207. PubMed ID: 26408293 [TBL] [Abstract][Full Text] [Related]
4. LncRNA NORAD accelerates the progression and doxorubicin resistance of neuroblastoma through up-regulating HDAC8 via sponging miR-144-3p. Wang B; Xu L; Zhang J; Cheng X; Xu Q; Wang J; Mao F Biomed Pharmacother; 2020 Sep; 129():110268. PubMed ID: 32563146 [TBL] [Abstract][Full Text] [Related]
5. Tumor suppressive activity of miR-424-5p in breast cancer cells through targeting PD-L1 and modulating PTEN/PI3K/AKT/mTOR signaling pathway. Dastmalchi N; Hosseinpourfeizi MA; Khojasteh SMB; Baradaran B; Safaralizadeh R Life Sci; 2020 Oct; 259():118239. PubMed ID: 32784058 [TBL] [Abstract][Full Text] [Related]
6. MiR-125a-5p inhibits the proliferation and invasion of breast cancer cells and induces apoptosis by targeting GAB2. Wang LB; Feng L; He J; Liu B; Sun JG Math Biosci Eng; 2019 Jul; 16(6):6923-6933. PubMed ID: 31698596 [No Abstract] [Full Text] [Related]
7. MiR-216b inhibits cell proliferation by targeting FOXM1 in cervical cancer cells and is associated with better prognosis. He S; Liao B; Deng Y; Su C; Tuo J; Liu J; Yao S; Xu L BMC Cancer; 2017 Oct; 17(1):673. PubMed ID: 28978307 [TBL] [Abstract][Full Text] [Related]
8. miR-589-5p Inhibits Cell Proliferation by Targeting Histone Deacetylase 3 in Triple Negative Breast Cancer. Rahbari R; Rahimi K; Rasmi Y; Khadem-Ansari MH; Abdi M Arch Med Res; 2022 Jul; 53(5):483-491. PubMed ID: 35840467 [TBL] [Abstract][Full Text] [Related]
9. Suppressive role of miR-502-5p in breast cancer via downregulation of TRAF2. Sun LL; Wang J; Zhao ZJ; Liu N; Wang AL; Ren HY; Yang F; Diao KX; Fu WN; Wan EH; Mi XY Oncol Rep; 2014 May; 31(5):2085-92. PubMed ID: 24677135 [TBL] [Abstract][Full Text] [Related]
10. miR-328-5p inhibits MDA-MB-231 breast cancer cell proliferation by targeting RAGE. Luo T; Yan Y; He Q; Ma X; Wang W Oncol Rep; 2018 Jun; 39(6):2906-2914. PubMed ID: 29620238 [TBL] [Abstract][Full Text] [Related]
11. miR-211-5p is down-regulated and a prognostic marker in bladder cancer. Wang W; Liu Z; Zhang X; Liu J; Gui J; Cui M; Li Y J Gene Med; 2020 Dec; 22(12):e3270. PubMed ID: 32893379 [TBL] [Abstract][Full Text] [Related]
12. MiR-216a-5p act as a tumor suppressor, regulating the cell proliferation and metastasis by targeting PAK2 in breast cancer. Zhang Y; Lin P; Zou JY; Zou G; Wang WZ; Liu YL; Zhao HW; Fang AP Eur Rev Med Pharmacol Sci; 2019 Mar; 23(6):2469-2475. PubMed ID: 30964173 [TBL] [Abstract][Full Text] [Related]
13. DSCAM-AS1 promotes tumor growth of breast cancer by reducing miR-204-5p and up-regulating RRM2. Liang WH; Li N; Yuan ZQ; Qian XL; Wang ZH Mol Carcinog; 2019 Apr; 58(4):461-473. PubMed ID: 30457164 [TBL] [Abstract][Full Text] [Related]
14. MicroRNA-216b targets Liu T; Ye P; Ye Y; Han B Int J Biol Sci; 2021; 17(11):2970-2983. PubMed ID: 34345220 [TBL] [Abstract][Full Text] [Related]
15. MiRNA-138-5p: A strong tumor suppressor targeting PD-L-1 inhibits proliferation and motility of breast cancer cells and induces apoptosis. Rasoolnezhad M; Safaralizadeh R; Hosseinpourfeizi MA; Banan-Khojasteh SM; Baradaran B Eur J Pharmacol; 2021 Apr; 896():173933. PubMed ID: 33545160 [TBL] [Abstract][Full Text] [Related]
16. MiR-361-5p inhibits glycolytic metabolism, proliferation and invasion of breast cancer by targeting FGFR1 and MMP-1. Ma F; Zhang L; Ma L; Zhang Y; Zhang J; Guo B J Exp Clin Cancer Res; 2017 Nov; 36(1):158. PubMed ID: 29132384 [TBL] [Abstract][Full Text] [Related]
17. Pyridoxine 5'-phosphate oxidase is correlated with human breast invasive ductal carcinoma development. Ren W; Guan W; Zhang J; Wang F; Xu G Aging (Albany NY); 2019 Apr; 11(7):2151-2176. PubMed ID: 30982780 [TBL] [Abstract][Full Text] [Related]
18. [LncRNA RPL22P1-201 affects prostate cancer cell proliferation, cell cycle, and sensitivity to docetaxel by regulating miR-216b-5p expression]. Yang C; Xue JG Zhonghua Nan Ke Xue; 2023 Oct; 29(10):881-887. PubMed ID: 38639656 [TBL] [Abstract][Full Text] [Related]
19. miR-4732-5p promotes breast cancer progression by targeting TSPAN13. Wang YW; Zhao S; Yuan XY; Liu Y; Zhang K; Wang J; Zhu J; Ma R J Cell Mol Med; 2019 Apr; 23(4):2549-2557. PubMed ID: 30701690 [TBL] [Abstract][Full Text] [Related]
20. LncRNA KCNQ1OT1 acts as miR-216b-5p sponge to promote colorectal cancer progression via up-regulating ZNF146. Zhu S; Chen CY; Hao Y J Mol Histol; 2021 Jun; 52(3):479-490. PubMed ID: 33394291 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]